Enrofloxacin _ 60265ESEnrofloxacin is a veterinary fluoroquinolone (FQ) antibiotic with broad spectrum antimicrobial activity. FQ drugs chelate iron with high affinity. This chelation leads to the inhibition of Fe(II) dependent dioxygenases, which are involved in the regulation of epigenetic control, collagen maturation, and degradation of hypoxia inducible factor (HIF). Side effects associated with FQ drugs include nephrotoxicity and tendinopathy. Enrofloxacin is used in

Suitable for cell culture

the instrument needs to be calibrated once a year

the protein migrates to 90-115 kDa based on Tris-Bis PAGE result

The product's biological activity and batch-to-batch consistency are ensured through validation and testing of biological activity

Overlay each well with previously prepared DCFH-DA Solution

encoding type I transmembrane proteins with ITAM motifs (Fc gamma RII A and C) or ITIM motifs (Fc gamma RIIB) in their cytoplasmic domains

TNF RI is stored in the Golgi and translocates to the cell surface following proinflammatory stimuli

Regulatory compliant: Verified following EP 2

Potency (Anhydrous)：845-988 mcg/mg

FLJ16015 Protein

Monoclonal anti-SN38 antibody

The enzyme acts on the terminal dephosphorylation